Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10590109 Heterocyclic compounds used as FGFR inhibitors

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 31 Jul, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 31 Jul, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 11 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 11 Dec, 2023
Edits made to:
Article (+627 characters)
Article

Patent abstract

The present invention relates to a heterocyclic compound, a pharmaceutical composition containing the same, a preparation method thereof, and use thereof as a fibroblast growth factor receptor (FGFR) inhibitor. The compound is a heterocyclic compound as shown in Formula I, or a pharmaceutically acceptable salt, prodrug, solvent compound, polymorph, isomer or stable isotopic derivative thereof. The present invention further relates to use of the compound for the treatment or prevention of related diseases which are FGFR-mediated such as cancer, and a method for applying the compound to treat said diseases.

Edits on 4 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 4 Oct, 2023
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Chao Zhou0
Norman Xianglong Kong0
Zhixiang Zheng0
Edits on 25 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Mar, 2023
Edits on 23 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 23 Mar, 2023
Infobox
Is a
Patent
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
105901090
Date of Patent
March 17, 2020
0
Patent Application Number
162462360
Date Filed
January 11, 2019
0
Patent Citations Received
‌
US Patent 11247987 Inhibiting ubiquitin specific peptidase 30
0
‌
US Patent 11535618 Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors
0
Patent Primary Examiner
‌
Timothy R Rozof
0
Edits on 28 Dec, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 28 Dec, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11535618 Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors
0
Edits on 16 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 16 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11247987 Inhibiting ubiquitin specific peptidase 30
Edits on 2 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 2 Feb, 2022
Edits made to:
Infobox (+7 properties)
‌

 US Patent 10590109 Heterocyclic compounds used as FGFR inhibitors

Infobox
Is a
Patent
Patent
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10590109
Date of patent
March 17, 2020
Patent application number
16246236
Date Filed
January 11, 2019
Patent primary examiner
‌
Timothy R Rozof

Find more entities like US Patent 10590109 Heterocyclic compounds used as FGFR inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.